• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Inhibition by histamine of platelet-activating-factor-induced neutrophil chemotaxis in bronchial asthma.

作者信息

Rabier M, Damon M, Chanez P, Mencia-Huerta J M, Braquet P, Bousquet J, Michel F B, Godard P

机构信息

INSERM U-58, Montpellier, France.

出版信息

Int Arch Allergy Appl Immunol. 1989;89(2-3):314-7. doi: 10.1159/000234967.

DOI:10.1159/000234967
PMID:2759720
Abstract

Circulating human polymorphonuclear neutrophils are involved in asthma after their migration into the lung by local chemotactic factors. Investigation of the locomotion of neutrophils in Boyden chambers, showed that the chemotactic intensity of the platelet-activating factor (PAF) was similar in cells from healthy subjects and allergic asthmatics, although the optimal effect of the mediator was observed at 10(-6) M and 10(-8) M, respectively. Histamine had no direct chemoattractant effect on neutrophils but inhibited PAF-induced chemotaxis of neutrophils from healthy subjects and allergic asthmatics. This study provides additional evidence that neutrophils are involved in asthma, and points out the interaction between PAF and histamine in the migration of neutrophils to the lung.

摘要

相似文献

1
Inhibition by histamine of platelet-activating-factor-induced neutrophil chemotaxis in bronchial asthma.
Int Arch Allergy Appl Immunol. 1989;89(2-3):314-7. doi: 10.1159/000234967.
2
Neutrophil chemotactic activity of PAF, histamine and neuromediators in bronchial asthma.血小板活化因子、组胺及神经介质在支气管哮喘中的中性粒细胞趋化活性
J Lipid Mediat. 1991 Nov;4(3):265-75.
3
Effect of terfenadine on neutrophil and eosinophil chemotactic activities after inhalation of platelet-activating factor in vivo and on neutrophil chemotaxis in vitro.
Int Arch Allergy Immunol. 1992;97(3):181-6. doi: 10.1159/000236116.
4
The inhibitory effect of methotrexate on PAF-induced neutrophil and eosinophil locomotion in asthmatic patients.甲氨蝶呤对哮喘患者中血小板活化因子诱导的中性粒细胞和嗜酸性粒细胞趋化运动的抑制作用。
Asian Pac J Allergy Immunol. 1994 Jun;12(1):65-71.
5
Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
Immunopharmacol Immunotoxicol. 1996 Nov;18(4):587-95. doi: 10.3109/08923979609052755.
6
Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.特异性银杏内酯衍生的血小板活化因子(PAF)拮抗剂BN 52021对PAF诱导的人嗜酸性粒细胞和中性粒细胞趋化性以及PAF与人嗜酸性粒细胞和中性粒细胞结合的抑制作用。
J Allergy Clin Immunol. 1989 Jan;83(1):83-90. doi: 10.1016/0091-6749(89)90480-6.
7
Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species.血小板活化因子诱导的中性粒细胞迁移程度取决于分子种类。
J Immunol. 1990 Oct 15;145(8):2561-5.
8
No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics.在过敏性哮喘患者中,血小板活化因子诱导气道阻塞期间血浆组胺无增加。
Chest. 1993 Sep;104(3):806-10. doi: 10.1378/chest.104.3.806.
9
Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.血小板活化因子诱导的人嗜酸性粒细胞跨内皮迁移:内皮细胞动态作用的证据
Am J Respir Cell Mol Biol. 1993 Jan;8(1):77-82. doi: 10.1165/ajrcmb/8.1.77.
10
The effect of RP 59227, a platelet-activating factor antagonist, against antigen challenge and eosinophil and neutrophil chemotaxis in asthmatics.血小板活化因子拮抗剂RP 59227对哮喘患者抗原激发及嗜酸性粒细胞和中性粒细胞趋化性的作用。
J Lipid Mediat Cell Signal. 1994 Sep;10(3):345-53.

引用本文的文献

1
Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1).新型冠状病毒肺炎发病机制治疗新方法的实验性探索:H2受体抑制剂法莫替丁增强奥司他韦对感染A/PR/8/34(H1N1)小鼠的生存及免疫状态的影响
J Evol Biochem Physiol. 2022;58(1):230-246. doi: 10.1134/S0022093022010203. Epub 2022 Mar 5.
2
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.新型冠状病毒肺炎:法莫替丁、组胺、肥大细胞及作用机制
Front Pharmacol. 2021 Mar 23;12:633680. doi: 10.3389/fphar.2021.633680. eCollection 2021.
3
Does Famotidine Reduce the Risk of Progression to Severe Disease, Death, and Intubation for COVID-19 Patients? A Systemic Review and Meta-Analysis.
法莫替丁能否降低新冠病毒肺炎患者进展为重症疾病、死亡及插管的风险?一项系统评价与Meta分析
Dig Dis Sci. 2021 Nov;66(11):3929-3937. doi: 10.1007/s10620-021-06872-z. Epub 2021 Feb 24.
4
Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.法莫替丁对 COVID-19 住院患者临床结局的影响。
Am J Gastroenterol. 2020 Oct;115(10):1617-1623. doi: 10.14309/ajg.0000000000000832.
5
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.新型冠状病毒肺炎:法莫替丁、组胺、肥大细胞与作用机制
Res Sq. 2020 Aug 31:rs.3.rs-30934. doi: 10.21203/rs.3.rs-30934/v2.
6
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro.罗红霉素、克拉霉素和阿奇霉素可减轻生物活性磷脂在体外对人呼吸道上皮的损伤作用。
Inflammation. 1997 Dec;21(6):655-65. doi: 10.1023/a:1027342424205.